MedPath

A comparative study of 0.5% ropivacaine with combination of 0.5% bupivacaine and 2% lidocaine on intraocular pressure before and after peribulbar block in cataract surgery

Phase 4
Conditions
Health Condition 1: H251- Age-related nuclear cataractHealth Condition 2: H251- Age-related nuclear cataract
Registration Number
CTRI/2024/03/064131
Lead Sponsor
BLDE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Uncomplicated cataract.

2)Normal intraocular pressure

Exclusion Criteria

1)Patients with cognitive impairment.

2)Patients allergic to hyaluronidase, lidocaine, ropivacaine and bupivacaine.

3)Any other surgeries combined with cataract.

4)Patients with hypertension and coronary artery disease in lignocaine group.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)The study will help us to study the adverse effects caused by raised intra ocular pressure post peribulbar block and reduce the side effects caused by prolonged motor blockade by using a low concentrated anesthetic. <br/ ><br> <br/ ><br>2)This study will help us to know an ideal drug for peribulbar block with minimal complications. <br/ ><br>Timepoint: 31 cases in 6months and total 62 cases in 1 year <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
This study will help us to know an ideal drug for peribulbar block with minimal complications. <br/ ><br>Timepoint: 31 cases in 6months and total 62 cases in 1 year <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath